483 filings
Page 9 of 25
8-K
y9h66vkwp2b6
2 Apr 13
Departure of Directors or Certain Officers
12:00am
8-K
f5sdpjqf
26 Mar 13
Alexza Reports 2012 Fourth Quarter and Full Year Financial Results
12:00am
8-K
d8xenko
13 Mar 13
Peter W. Schineller Joins Alexza Pharmaceuticals
12:00am
8-K
4iogi wovjgovb
21 Feb 13
Other Events
12:00am
8-K
k1x19 67a
8 Feb 13
Departure of Directors or Certain Officers
12:00am
S-8
6lskimw8
28 Jan 13
Registration of securities for employees
12:00am
8-K
nurta1olwd3ti
3 Jan 13
Alexza Pharmaceuticals Appoints J. Kevin Buchi to its Board of Directors
12:00am
8-K
2x1yc b1190p7ipxwd07
21 Dec 12
U.S. FDA Approves Alexza’s ADASUVE® (loxapine) Inhalation Powder
12:00am
8-K
nvtc0trd0pvtnbcw06t
14 Dec 12
Other Events
12:00am
CT ORDER
s9xv0d12
3 Dec 12
Confidential treatment order
12:00am
8-K
2lznwihunpp5iek00p6
19 Nov 12
Alexza Pharmaceuticals Receives Updated Day 180 List of Outstanding Issues for ADASUVE™ (Staccato® Loxapine) MAA
12:00am
8-K
6p90j
6 Nov 12
Alexza Reports 2012 Third Quarter Financial Results
12:00am
8-K
q9na1b
24 Sep 12
Other Events
12:00am
424B5
oo73 vc8ln
24 Sep 12
Prospectus supplement for primary offering
12:00am
424B5
rwld8mio8vox
23 Aug 12
Prospectus supplement for primary offering
12:00am
8-K
j2tr7u18v239dyo
23 Aug 12
Other Events
12:00am
8-K
wmyjj7a4jdn1gc8
22 Aug 12
Alexza Pharmaceuticals Receives EU Certificate of GMP Compliance
12:00am
8-K
h8zim2lrv2id6u0a
8 Aug 12
Alexza Reports 2012 Second Quarter Financial Results
12:00am